A5075989688- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Monoclonal and Polyclonal Antibodies Research
- Systemic Lupus Erythematosus Research
- Long-Term Effects of COVID-19
- Diabetes and associated disorders
- Immunodeficiency and Autoimmune Disorders
- Hematopoietic Stem Cell Transplantation
- Rheumatoid Arthritis Research and Therapies
- Blood groups and transfusion
- Systemic Sclerosis and Related Diseases
- Digestive system and related health
- Cytokine Signaling Pathways and Interactions
- Glycosylation and Glycoproteins Research
- Liver Diseases and Immunity
- Acute Myeloid Leukemia Research
- Vitamin D Research Studies
- COVID-19 Impact on Reproduction
- Celiac Disease Research and Management
- Renal Transplantation Outcomes and Treatments
- Lymphoma Diagnosis and Treatment
- Gut microbiota and health
Evangelismos Hospital
2016-2025
Areté Associates (United States)
2023
Agios Pavlos General Hospital
2022
Larnaca College
2017
National and Kapodistrian University of Athens
2016
Anti-SARS-CoV-2 spike RBD (receptor-binding domain) IgG antibody levels were monitored in 1643 volunteer healthcare workers of Eginition, Evangelismos, and Konstantopoulio General Hospitals (Athens, Greece), who underwent vaccination with two doses COVID-19 BNT162b2 mRNA vaccine (Pfizer) had no history SARS-CoV-2 infection. Venous blood was collected 20-30 days after the second dose anti-RBD determined using CMIA II Quant (Abbott) on ARCHITECT i System or ADVIA Centaur (Siemens) XP platform....
In the realm of DNA testing with legal implications, reliability and precision genetic markers play a pivotal role in confirming or negating paternity claims. This study aimed to assess potential utility human leukocyte antigen (HLA) gene polymorphism through massively parallel sequencing (MPS) technology as robust forensic for parentage involving deficiencies. It sought redefine significance HLA genes this context. Data on autosomal short tandem repeat (aSTR) mutational events across 18...
HLA‐C * 01:02:01:70 differs from the 01:02:01:01 allele by one nucleotide substitution in intron 4.
HLA‐C * 04:01:01:174 differs from the 04:01:01:06 allele by one nucleotide substitution in intron 5.
The HLA-DQB1*03:01:01:64 allele differs from HLA-DQB1*03:01:01:03 by a single nucleotide substitution in intron 2.
The HLA-DQB1*06:02:01:40 allele differs from HLA-DQB1*06:02:01:01 by a single nucleotide substitution in intron 2.
HLA‐A*01:01:01:112 differs from the HLA‐A*01:01:01:01 allele by one nucleotide substitution in 5'UTR.
HLA‐B*41:02:01:11 and ‐C*08:266 were detected in a solid organ recipient during the HLA typing process.
HLA‐B*47:01:01:07 differs from the HLA‐B*47:01:01:03 allele by one nucleotide deletion in 3′UTR.
HLA‐C*17:01:01:29 differs from the HLA‐C*17:01:01:05 allele by one nucleotide substitution in 3′UTR.
Characterisation of the novel HLA‐C*07:01:01:141 allele in a 23‐year‐old Greek bone marrow donor.
The HLA‐DRB1*03:218N allele differs from HLA‐DRB1*03:174N by a single nucleotide substitution in exon 2.